How to appeal a UnitedHealthcare kidney disease — ckd, esrd, igan, adpkd denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

UnitedHealthcare-specific note: UHC's parent UnitedHealth Group owns Optum (PBM Optum Rx) and Surest. Surest plans have different cost-sharing rules. State complaints flow to state insurance department + DOL/EBSA for self-funded.

What UnitedHealthcare's policy requires for kidney disease — ckd, esrd, igan, adpkd

Cited policy: OptumRx Prior Authorization Criteria — Budesonide Enteric-Release (Tarpeyo)

IgAN biopsy-confirmed + max-tolerated RAASi >=3 months + persistent UPCR >=0.8 g/g or proteinuria >=1 g/day. Specialist Rx (nephrologist).

How UnitedHealthcare denies kidney disease — ckd, esrd, igan, adpkd — and how to counter it

Where UnitedHealthcare pushes back: 1) RAASi not max-tolerated long enough; 2) Proteinuria threshold not met; 3) PA template incomplete.

Counter-arguments that hold up: Document max-tolerated RAASi (lisinopril 40mg or losartan 100mg etc.) >=3 months with UPCR/24-hr protein documentation. NefIgArd Part B full approval Dec 2023 (not just accelerated). KDIGO 2021 GN guideline.

What UnitedHealthcare typically denies for kidney disease — ckd, esrd, igan, adpkd

Across UnitedHealthcare's commercial and Medicare books, denials cluster around a small number of patterns. For kidney disease — ckd, esrd, igan, adpkd, expect:

• GLP-1 weight-loss exclusion
• Out-of-network reduction citing UCR
• Step therapy on biologics
• Prior auth denied for advanced imaging
• Quantity limits on specialty drugs

Treatments most often denied in this category

These are the kidney disease — ckd, esrd, igan, adpkd treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Tarpeyo (IgAN)
• Filspari
• Farxiga (CKD)
• Jardiance (CKD)
• Kerendia
• Jynarque (ADPKD)

How to submit the appeal to UnitedHealthcare

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document UnitedHealthcare cited in the denial.
3. File the appeal through UnitedHealthcare's portal (members: https://www.myuhc.com ; providers: https://www.uhcprovider.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MN, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See UnitedHealthcare's prior-authorization criteria by drug: UnitedHealthcare PA criteria on ApprovalHelp.